TG Therapeutics logo
TG Therapeutics TGTX
$ 24.36 0.0%

Quarterly report 2024-Q2
added 08-09-2024

report update icon

TG Therapeutics Operating Income 2011-2024 | TGTX

Annual Operating Income TG Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
20.6 M -193 M -345 M -274 M -169 M -174 M -119 M -79 M -63.2 M -55.7 M -23 M -26.9 M -882 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
20.6 M -345 M -115 M

Quarterly Operating Income TG Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
8.82 M -9.27 M - 115 M -44.7 M -37 M - -35 M -38.9 M -66.9 M - -85.1 M -77.5 M -89.2 M - -85.7 M -50.8 M -50.2 M - -60.9 M -35.5 M -34.7 M - -34.3 M 44.3 M -41.6 M - -31.6 M -28.4 M -27.7 M - -24.9 M -16 M -14 M - -13.8 M -17.1 M -14.6 M - -17.4 M -12 M -7.61 M - -4.65 M -6.63 M -3.71 M - -2.71 M -3.1 M -17.4 M - -30.1 K -297 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
115 M -89.2 M -24.3 M